Negative Predictive Value of Allergologic Work-Up with Iodinated Contrast Media in ‘Real-Life’ Practice
Authors:
- Krzysztof SpecjalskiKSKrzysztof Specjalski
- Ilona IwaszkoIIIlona Iwaszko
- Dominik TypiakDTDominik Typiak
- Dawid JuszkiewiczDJDawid Juszkiewicz
- Wiktoria SzablewskaWSWiktoria Szablewska
- Mateusz SkotnickiMSMateusz Skotnicki
- Nicola LeNLNicola Le
- Michał PowietrzyńskiMPMichał Powietrzyński
- Adam StrukowskiASAdam Strukowski
- Joanna ŚledzikJŚJoanna Śledzik
- Marta ChełmińskaMCMarta Chełmińska
- Marek NiedoszytkoMNMarek Niedoszytko
Open Access
- 10 July 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5425
Abstract
Background: Several strategies such as premedication or allergologic work-up have been used to facilitate safe iodinated contrast media (ICM) application. The aim of this study was to assess the negative predictive value of skin tests and complete allergologic work-up with iodinated contrast media in real-life settings. Methods: We retrospectively enrolled 210 patients with a history of immediate hypersensitivity reactions to ICMs. The stepwise protocol of selecting safe ICMs included skin prick tests (SPTs), intracutaneous tests (ICTs), and intravenous drug provocation tests (DPTs). The tests were performed with one or more of the following medications: iohexol, iodixanol, iomeprol, iopromide, and ioversol. At least 6 months after selecting safe ICMs, a telephone follow-up was scheduled. Based on this data, negative predictive values of skin tests and the whole work-up were calculated. Results: Overall, we obtained the following rates of positive tests: SPT—12% (55/441); ICT—10% (40/383); and DPT—5% (10/195). The highest rates of positive work-ups were found in patients tested within 1 year after the reaction and patients with a history of urticaria/angioedema after ICMs. The skin tests and DPTs determined a safe ICM in 184/210 (87%) patients. The negative predictive value of skin tests in reference to DPTs in hospital settings was 95%. Finally, a telephone follow-up demonstrated that 75/184 participants (41%) had been given the recommended ICM, including 68 cases (37%) with no subsequent hypersensitivity reaction and 7 (4%) with a reaction. The negative predictive value of allergologic work-up consisting of SPTs, ICTs and DPTs in real-life settings was 90%. Conclusions: Skin tests and intravenous drug provocation tests with ICMs are characterised by high negative predictive value, and enable the determination of safe ICMs for most patients.Keywords
Funding Information
- Uniwersytet Gdański (61-00206)
This publication has 50 references indexed in Scilit:
- Risk factors associated with immediate hypersensitivity reaction to contrast media: a systematic review and meta-analysisEuropean Journal of Radiology, 2025
- IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paperWorld Allergy Organization Journal, 2020
- Skin Testing for Suspected Iodinated Contrast Media HypersensitivityThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patientsAnnals of Allergy, Asthma & Immunology, 2017
- Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologistMayo Clinic Proceedings, 2012
- A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactionsJournal of Allergy and Clinical Immunology, 2012
- Percutaneous coronary interventions in EuropeClinical Research in Cardiology, 2007
- X-ray contrast media—an overviewToxicology, 2005
- Lack of Penicillin Resensitization in Patients With a History of Penicillin Allergy After Receiving Repeated Penicillin CoursesArchives of internal medicine (1960), 2002
- Skin testing to detect penicillin allergyJournal of Allergy and Clinical Immunology, 1981